EmcrownOngoing Studies
Click here to participate in any ongoing study.
We are currently enrolling participants for studies in the following areas:
1. TOURETTE’S SYNDROME (NCT06315751)
Do you have Tourette Syndrome and want an alternative to current treatments? This trial will investigate if a potential treatment can reduce Tourette Syndrome symptoms. Find out more about it from our study team.
2. ASTHMA (NCT06529419)
LEVANTE is a new clinical study looking at a potential new treatment to help people with asthma, who are at a high risk of having a flare-up of symptoms.
3. Chronic Kidney Disease (NCT06087835)
Do you have Chronic Kidney Disease (CKD) with high levels of protein in your urine? Emcrown is conducting a phase-3 research to find out whether combining zibotentan with dapagliflozin may help in people with CKD, especially those with high proteinuria.
4. Tourette’s Disorder (NCT06021522)
Tourette’s affects millions of children, adults and adolescents globally. This study seeks to test the efficacy of Ecopipam that can potentially help.
5. Hypertension. (NCT06272487)
Many people struggle to keep their blood pressure under control, even with prescription medications. This study aims to evaluate if zilebesiran can safely lower blood pressure in people with high blood pressure who are taking 2 to 4 hypertension medications and have an increased risk of experiencing a cardiovascular event.